-
PROMISE OF REAL-WORLD DATA NETWORKS: INNOVATIONS IN TRIAL DESIGN USING PCORNET®
Mar 18, 2026, 21:38 PM -
REAL-WORLD INSIGHTS ON CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI: DATA FROM A LARGE FERTILITY EMR DATABASE IN THE US (2010 - 2024)
Mar 18, 2026, 21:38 PM -
POPULATION CHARACTERISTICS AND CLINICAL MEDICATION PATTERNS OF COUGH PATIENTS IN CHINA BASED ON REGIONAL REAL-WORLDDATA
Mar 18, 2026, 21:38 PM -
AUTOMATION OF SYSTEMATIC REVIEWS WITH LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
COMMERCIAL PAYER COVERAGE OF BIOSIMILARS: 2017-2024
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING-BASED PREDICTION OF 10-YEAR CORONARY HEART DISEASE RISK AND COMPARISON WITH THE FRAMINGHAM RISK SCORE
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) AMONG WOMEN WITH VASOMOTOR SYMPTOMS (VMS) WITH AND WITHOUT DEPRESSION: A MEPS ANALYSIS
Mar 18, 2026, 21:38 PM -
EQ-5D BASED UTILITY VALUES BY CLINICAL RESPONSE AND SYMPTOM SEVERITY IN JAPANESE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: POST-HOC ANALYSIS OF JAPANESE BREXPIPRAZOLE CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
INTEGRATING GENERATIVE ARTIFICIAL INTELLIGENCE (AI) INTO BIOSTATISTICAL WORKFLOWS FOR TRIAL EMULATION: A FRAMEWORK TO ACCELERATE REAL-WORLD EVIDENCE GENERATION
Mar 18, 2026, 21:38 PM -
PREDICTING OVERALL SURVIVALIN NON-SMALL CELL LUNG CANCER PATIENTSRECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPYUSING A JOINT MODEL INTEGRATING SERIAL GENETIC AND EPIGENETIC BIOMARKERS
Mar 18, 2026, 21:38 PM -
CONTENT VALIDITY OF THE EQ-HWB-9 IN PATIENTS WITH ADVANCED ILLNESSES: A COGNITIVE DEBRIEFING STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE POST-MARKETING SAFETY STUDY OF NIRSEVIMAB AND PALIVIZUMAB: A PHARMACOVIGILANCE ANALYSIS USING FAERS AND WHO VIGIACCESS
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH HEALTHCARE COSTS AND DISEASE PROGRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS IN THE US REAL-WORLD SETTING
Mar 18, 2026, 21:38 PM -
PCV20 FOR HIGH-RISK POPULATIONS: A COST-UTILITY ANALYSIS FROM THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE
Mar 18, 2026, 21:38 PM -
IMPACT OF LUPUS NEPHRITIS FLARES ON HEALTHCARE UTILIZATION: A RETROSPECTIVE COHORT STUDY IN THE UNITED STATES BETWEEN 2016 AND 2025
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK AND COMORBIDITY BURDEN IN JAPANESE PATIENTS WITH MYASTHENIA GRAVIS A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
HOW PAYERS READ THE TEA LEAVES: ECONOMIC AND FORMULARY SIGNALS FROM IRA AND MFN?
Mar 18, 2026, 21:38 PM -
AUTOMATING EVIDENCE GAP ANALYSIS USING A MULTI-AGENT AI FRAMEWORK: A MASH CASE STUDY
Mar 18, 2026, 21:38 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEPATITIS DELTA VIRUS RNA-BASED SURROGATE ENDPOINTS AND LONG-TERM CLINICAL OUTCOMES IN HEPATITIS DELTA VIRUS INFECTION: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LOW-DOSE ATROPINE VERSUS ORTHOKERATOLOGY FOR MYOPIA CONTROL IN CHILDREN
Mar 18, 2026, 21:38 PM
